»Ê¼Ò»ªÈË

These Transformational Research Awards support advanced pre-clinical translational research, clinical studies or trials to develop and test new treatments, diagnostics or other technologies, or for the establishment of the evidence required for the uptake of improved treatments or technologies into the NHS. Research funded through this scheme should aim to accelerate progress towards a transformational change in prevention, diagnosis, treatment, or care for people affected by blood cancer.

This scheme supports large-scale clinical trials that have significant potential to improve the survival for those affected by the hardest-to-treat blood cancers.